Infiltrative Lymphoma-Associated Bradycardia and Cardiac Conduction Abnormalities
- PMID: 34396220
- PMCID: PMC8352037
- DOI: 10.1016/j.jaccao.2020.01.002
Infiltrative Lymphoma-Associated Bradycardia and Cardiac Conduction Abnormalities
Keywords: ABVD, adriamycin, bleomycin, vinblastine, dacarbazine; CMR, cardiac magnetic resonance; ECG, electrocardiography; EF, ejection fraction; FDG, fluorodeoxyglucose; LGE, late gadolinium enhancement; PET-CT, positron emission tomography-computed tomography; R-EPOCH, ritixubimab, etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin; TTE, transthoracic echocardiography; TVP, transvenous pacemaker; bradycardia; cardiac magnetic resonance; cardiac masses; conduction disease; lymphoma; pacemaker.
Figures

References
-
- Palaskas N.T.K., Gladish G., Agha A.M. Evaluation and management of cardiac tumors. Curr Treat Options Cardiovasc Med. 2018;20:29. - PubMed
-
- McDonnell P.J.M.R., Bulkley B.H. Involvement of the heart by malignant lymphoma: a clinicopathologic study. Cancer. 1982;49:944–951. - PubMed
-
- Chinen K., Izumo T. Cardiac involvement by malignant lymphoma: a clinicopathologic study of 25 autopsy cases based on the WHO classification. Ann Hematol. 2005;84:498–505. - PubMed